This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
$44.15
Share price
0.00%
Change (1 day)
118.89%
Change (1 year)
Categories
Albireo Pharma (ALBO) - Cash on Hand
Cash on Hand as of September 2022 : $0.22 Billion USD
According to Albireo Pharma's latest financial reports the company has $0.22 Billion USD in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Albireo Pharma - Cash on Hand chart (from 2005 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2021-12-31 | $0.24 B | -1.26% |
| 2020-12-31 | $0.25 B | 90.58% |
| 2019-12-31 | $0.13 B | -19.55% |
| 2018-12-31 | $0.16 B | 207.88% |
| 2017-12-31 | $53.23 M | 77.85% |
| 2016-12-31 | $29.93 M | |
| 2016-09-30 | $28.68 M | -29.77% |
| 2015-09-30 | $40.84 M | 66.12% |
| 2014-09-30 | $24.58 M | -38.19% |
| 2013-09-30 | $39.78 M | 1.87% |
| 2012-09-30 | $39.05 M | 0.9% |
| 2011-09-30 | $38.7 M | 33.81% |
| 2010-09-30 | $28.92 M | -47.07% |
| 2009-09-30 | $54.64 M | -39.48% |
| 2008-09-30 | $90.28 M | 12.82% |
| 2007-09-30 | $80.02 M | 356.25% |
| 2006-09-30 | $17.53 M | 4666.03% |
| 2005-09-30 | $0.36 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -8.43% | 🇺🇸 USA |